Megan is certainly a class act and stands above many of her fellow industry CEO’s.
OPT is my first ”i wish had invested in that” stocks. whilst wider market mechanisms are at play today, great to see the OPT team finally see the market appreciate their great work.
Still unsure re the delta of control to drug, but look forward to the full analysis to clarify the control group outperformance.
- Forums
- ASX - By Stock
- Ann: Opthea Meets Primary Endpoint in Phase 2b Study of OPT-302
Megan is certainly a class act and stands above many of her...
Featured News
Add OPT (ASX) to my watchlist
|
|||||
Last
56.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $695.5M |
Open | High | Low | Value | Volume |
57.5¢ | 57.5¢ | 55.0¢ | $706.9K | 1.260M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 79437 | 55.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
57.0¢ | 174437 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 29437 | 0.555 |
2 | 47582 | 0.550 |
1 | 29437 | 0.545 |
2 | 7254 | 0.540 |
4 | 21773 | 0.530 |
Price($) | Vol. | No. |
---|---|---|
0.570 | 174437 | 2 |
0.575 | 59437 | 2 |
0.580 | 38513 | 7 |
0.590 | 15500 | 1 |
0.595 | 103600 | 2 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |